These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Preventative policies in transfusion associated graft versus host disease in the treatment of cancer. Webb DK Arch Dis Child; 1994 Dec; 71(6):532-3. PubMed ID: 7726615 [TBL] [Abstract][Full Text] [Related]
25. Use of irradiated blood components: practice parameter. Przepiorka D; LeParc GF; Stovall MA; Werch J; Lichtiger B Am J Clin Pathol; 1996 Jul; 106(1):6-11. PubMed ID: 8701934 [TBL] [Abstract][Full Text] [Related]
26. Transfusion-associated graft-versus-host disease: report of an occurrence following the administration of irradiated blood. Lowenthal RM; Challis DR; Griffiths AE; Chappell RA; Goulder PJ Transfusion; 1993 Jun; 33(6):524-9. PubMed ID: 8516797 [TBL] [Abstract][Full Text] [Related]
27. Irradiation of fresh whole blood for prevention of transfusion-associated graft-versus-host disease does not impair platelet function and clinical hemostasis after open heart surgery. Lavee J; Shinfeld A; Savion N; Thaler M; Mohr R; Goor DA Vox Sang; 1995; 69(2):104-9. PubMed ID: 8585189 [TBL] [Abstract][Full Text] [Related]
28. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease. Shivdasani RA; Anderson KC Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271 [TBL] [Abstract][Full Text] [Related]
33. Developments in the prevention of transfusion-associated graft-versus-host disease. Fast LD Br J Haematol; 2012 Sep; 158(5):563-8. PubMed ID: 22734439 [TBL] [Abstract][Full Text] [Related]
34. Transfusion of pathogen-reduced platelet components without leukoreduction. Sim J; Tsoi WC; Lee CK; Leung R; Lam CCK; Koontz C; Liu AY; Huang N; Benjamin RJ; Vermeij HJ; Stassinopoulos A; Corash L; Lie AKW Transfusion; 2019 Jun; 59(6):1953-1961. PubMed ID: 30919465 [TBL] [Abstract][Full Text] [Related]
35. Transfusion-associated graft versus host disease. Parshuram C; Doyle J; Lau W; Shemie SD Pediatr Crit Care Med; 2002 Jan; 3(1):57-62. PubMed ID: 12793924 [TBL] [Abstract][Full Text] [Related]
36. Implementation of a blood irradiation program at a community cancer center. Patton GA; Skowronski MG Transfusion; 2001 Dec; 41(12):1610-6. PubMed ID: 11778080 [TBL] [Abstract][Full Text] [Related]
37. Recommendations on Selection and Processing of RBC Components for Pediatric Patients From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative. Zantek ND; Parker RI; van de Watering LM; Josephson CD; Bateman ST; Valentine SL; Delaney M; ; Pediatr Crit Care Med; 2018 Sep; 19(9S Suppl 1):S163-S169. PubMed ID: 30161072 [TBL] [Abstract][Full Text] [Related]
38. Audit of pediatric transfusion practices in a tertiary care hospital. Bahadur S; Sethi N; Pahuja S; Pathak C; Jain M Indian J Pediatr; 2015 Apr; 82(4):333-9. PubMed ID: 24794324 [TBL] [Abstract][Full Text] [Related]
39. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting. Ahya R; Douglas JG; Watson HG Heart; 1998 Sep; 80(3):299-300. PubMed ID: 9875094 [TBL] [Abstract][Full Text] [Related]
40. Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem. Jawa RS; Young DH; Stothert JC; Kulaylat MN; Landmark JD J Intensive Care Med; 2015 Mar; 30(3):123-30. PubMed ID: 23792801 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]